Certara

Create an alert
to follow the executive moves at Certara.

Most searched biographies at Certara

• William Feehery, Chief Executive Officer and Director
• Stephen Mclean, Director
• Eric Liu, Director

Click on an executive to view his biography >

Latest M&A news in Pharmaceuticals.

CVC Capital Partners has announced the acquisition of MedRisk (posted on Feb 24, 2021).
Jazz Pharmaceuticals has announced the acquisition of GW Pharmaceuticals (posted on Feb 4, 2021).
Nordic Capital has announced the acquisition of Advanz Pharma (posted on Feb 1, 2021).

Other contacts in the Pharmaceuticals industry

• Albert Bourla - Chief Executive Officer and Chairman of the Board at Pfizer
• Per-Olof Attinger - Executive Committee Secretary at Roche
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann

Learn more about the Pharmaceuticals industry >

Latest news about Certara

Certara Opens New China Office in Shanghai - Certara
Certara Announces Strategic Initiatives to Bolster Clinical Trial Transparency and Disclosure Services - Certara
Certara Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering - Certara
Certara Announces Series of White Papers on Disruptive Trends in U.S. Market Access - Certara
Food and Drug Administration Renews and Expands Use of Certara’s Biosimulation Software for Reviewing Regulatory Submissions - Certara

Certara on Wikipedia, Google News & Yahoo Finance

Certara on LinkedIn, Twitter & YouTube

Certara has 2,045 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).

Contact by email its executives including William Feehery

Call Certara at +1 314....

View the org chart

Register to receive your alert

Report an error